Literature DB >> 9785458

Paxillin.

C E Turner1.   

Abstract

Paxillin is a 68 kDa cytoplasmic protein that localizes to discrete sites of cell attachment to the extracellular matrix called focal adhesions. It is a multi-domain adapter protein capable of interacting with several structural and signaling proteins including vinculin, FAK, PYK2, Src and Crk. Phosphorylation of paxillin in response to integrin-mediated cell adhesion and growth factor stimulation regulates some of these interactions. Thus, paxillin functions as a scaffold for the recruitment of molecules into a signal transduction complex that is closely apposed to the plasma membrane. This is likely to facilitate the efficient processing of external stimuli that modulate important cellular events including cell adhesion, cell motility and growth control. Since paxillin interacts with several proteins known to cause cell transformation, the binding sites for these proteins on paxillin represent potential targets for therapeutic agents.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9785458     DOI: 10.1016/s1357-2725(98)00062-4

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  55 in total

Review 1.  Focal adhesion kinases: interest in immunoendocrinology, developmental biology, and cancer.

Authors:  H J Martens; V Geenen
Journal:  Endocrine       Date:  2000-12       Impact factor: 3.633

2.  A src family tyrosine kinase inhibits neurotransmitter release from neuronal cells.

Authors:  H Ohnishi; S Yamamori; K Ono; K Aoyagi; S Kondo; M Takahashi
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-04       Impact factor: 11.205

Review 3.  Laminins in peripheral nerve development and muscular dystrophy.

Authors:  Wei-Ming Yu; Huaxu Yu; Zu-Lin Chen
Journal:  Mol Neurobiol       Date:  2007-06       Impact factor: 5.590

4.  LNK (SH2B3) is a key regulator of integrin signaling in endothelial cells and targets α-parvin to control cell adhesion and migration.

Authors:  Julie Devallière; Mathias Chatelais; Juliette Fitau; Nathalie Gérard; Philippe Hulin; Laura Velazquez; Christopher E Turner; Béatrice Charreau
Journal:  FASEB J       Date:  2012-03-21       Impact factor: 5.191

5.  Involvement of Hic-5 in platelet activation: integrin alphaIIbbeta3-dependent tyrosine phosphorylation and association with proline-rich tyrosine kinase 2.

Authors:  M Osada; T Ohmori; Y Yatomi; K Satoh; S Hosogaya; Y Ozaki
Journal:  Biochem J       Date:  2001-05-01       Impact factor: 3.857

6.  Protein tyrosine phosphatase phi regulates paxillin tyrosine phosphorylation and mediates colony-stimulating factor 1-induced morphological changes in macrophages.

Authors:  F J Pixley; P S Lee; J S Condeelis; E R Stanley
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

7.  A new paxillin-binding protein, PAG3/Papalpha/KIAA0400, bearing an ADP-ribosylation factor GTPase-activating protein activity, is involved in paxillin recruitment to focal adhesions and cell migration.

Authors:  A Kondo; S Hashimoto; H Yano; K Nagayama; Y Mazaki; H Sabe
Journal:  Mol Biol Cell       Date:  2000-04       Impact factor: 4.138

8.  Altered focal adhesion regulation correlates with cardiomyopathy in mice expressing constitutively active rac1.

Authors:  M A Sussman; S Welch; A Walker; R Klevitsky; T E Hewett; R L Price; E Schaefer; K Yager
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

9.  Paxillin is involved in the differential regulation of endothelial barrier by HGF and VEGF.

Authors:  Anna A Birukova; Ivan Cokic; Nurgul Moldobaeva; Konstantin G Birukov
Journal:  Am J Respir Cell Mol Biol       Date:  2008-07-29       Impact factor: 6.914

10.  Discrete proteolysis of focal contact and adherens junction components in Porphyromonas gingivalis-infected oral keratinocytes: a strategy for cell adhesion and migration disabling.

Authors:  Edith Hintermann; Susan Kinder Haake; Urs Christen; Andrew Sharabi; Vito Quaranta
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.